BioDiscovery launches the NxClinical Center of Excellence initiative with Victorian Clinical Genetics Services as its first partner
PerkinElmer Genomics has selected BioDiscovery's NxClinical software as its choice for genomic data analysis for its services.
Nexus Copy Number 10.0 is a highly robust, intuitive, and multi-platform software for both copy number calling and downstream statistical analyses. A key feature of Nexus Copy Number is its ability to derive high quality copy number calls from many flavors of NGS (whole exome, whole genome, shallow, targeted panel, and normal depth of coverage sequencing).
NxClinical 4.1 is a unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.
BioDiscovery, a leader in copy number analysis software, created a new tailored software solution (Nexus Express for OncoScan) for copy number detection and downstream analysis for the OncoScan™ CNV Assay. The assay plus software solution allows researchers performing solid tumor analysis a high-quality, complete, end-to-end solution from raw data to discovery for difficult FFPE samples.
BioDiscovery announced today an agreement with Be Creative Lab in Beijing, China to be the exclusive reseller and distributor of BioDiscovery products in China.
BioDiscovery launches NxClinical 4.0, a unique system allowing analysis and interpretation of CNV, SNV, and AOH from a single NGS assay.
The new features in Nexus Copy Number 9.0 really enhance the usability of WES, WGS, targeted panels and low-pass sequencing for copy number analysis.
Nexus Copy Number 8.0 is derivation of copy number from NGS results. BAM (pooled reference), detects copy number from WES, WGS, and targeted NGS panels.